Your browser doesn't support javascript.
loading
Long-term Efficacy and Safety of Up to 108 Weeks of Ixekizumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis: The IXORA-PEDS Randomized Clinical Trial.
Paller, Amy S; Seyger, Marieke M B; Magariños, Gabriel A; Pinter, Andreas; Cather, Jennifer C; Rodriguez-Capriles, Claudia; Zhu, Danting; Somani, Najwa; Garrelts, Alyssa; Papp, Kim A.
Afiliação
  • Paller AS; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Seyger MMB; Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Magariños GA; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Pinter A; Psoriahue, Buenos Aires, Argentina.
  • Cather JC; Department of Dermatology, Venereology and Allergology, University Hospital Frankfurt, Frankfurt am Main, Germany.
  • Rodriguez-Capriles C; Mindful Dermatology and Modern Research Associates, Dallas, Texas.
  • Zhu D; Eli Lilly and Company, Indianapolis, Indiana.
  • Somani N; Eli Lilly and Company, Indianapolis, Indiana.
  • Garrelts A; Eli Lilly and Company, Indianapolis, Indiana.
  • Papp KA; Eli Lilly and Company, Indianapolis, Indiana.
JAMA Dermatol ; 158(5): 533-541, 2022 05 01.
Article em En | MEDLINE | ID: mdl-35416908
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Anticorpos Monoclonais Humanizados Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Child / Female / Humans Idioma: En Revista: JAMA Dermatol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Anticorpos Monoclonais Humanizados Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Child / Female / Humans Idioma: En Revista: JAMA Dermatol Ano de publicação: 2022 Tipo de documento: Article